Lansoprol

Medicinal product

(Invented) name

Lansoprol

Active substance (s)

Lansoprazolas

Strength

15 mg

Pharmaceutical form

skrandyje neirios kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A02BC03, Lansoprazole

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-12-19

Date of renewal

Documents

3089_Lansoprol 15 mg_PZ_2025-12-19.docx

3089_Lansoprol 15 mg_PL_2025-12-19.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Lansoprazolas	15 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119487	105593	1105593	lizdinė plokštelė	N28		Receptinis	LT/L/25/3089/001	Netiekiama	-	-	No	-	-	Download
119488	105594	1105594	lizdinė plokštelė	N56		Receptinis	LT/L/25/3089/002	Netiekiama	-	-	No	-	-
119489	105595	1105595	lizdinė plokštelė	N84		Receptinis	LT/L/25/3089/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-12-19	Registruotas